Back to Home


Martí Dalmases

PhD in Medicine | Master in Public Management – MBA | Master in Scientific Communication | Master in Hyperbaric Med

About Me

Currently, he collaborates as an active partner of ZBM Business Connect SL. He combines this work with his position as CEO of Ahead Therapeutics SL., a company dedicated to drug development, specifically, a technological platform based on nano-technology for treatment of auto-immune diseases, such as, Type 1 Diabetes and Multiple Sclerosis.

Martí has participated in the foundation and/or contributed to boost the growth of several technology-based companies, as an investor or consultant; and currently, he still is a member of the Board of some of them. TR Composites SL; SOM Biotech SL; Confirmsign SL; Centauri Biotech SL; Nanosel SL; IDP Discovery Pharma SL; Ahead Therapeutics SL.

He has also held responsibilities in different areas of the health sector: hospital planning and management; University teaching; planning pre and postgraduate programs; national and international consultancy in health policy; development of R&D projects in biomedicine as Technical Director of Univ. Parc Taulí Institute – UAB. He has worked actively in the field of scientific divulgation and teaching, being founder of the scientific journal “Educación Médica”.

Finally, Martí spent 5 years at KIM (Knowledge Innovation Market) as Director of HealthCare: teaching and technology transfer to improve the return on investment in R&D of Institutions and companies.

Recent tweets

If you're attending #INTA2023, let's make the most of the last days of this incredible experience! Let's meet, connect, and celebrate together for this wonderful opportunity! @INTA #trademarks

About a year ago from ZBM Patents's Twitter via Twitter Web App